Bank Of America Believes DAPT Adds To Precedent For PEGASUS Success For AstraZeneca
November 17, 2014 at 10:29 AM EST
In a report published Monday, Bank of America analyst Sachin Jain reiterated a Buy rating and $80.50 price target on AstraZeneca plc ...
